Active Shortage

TARO-MEROPENEM

SUN PHARMA CANADA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of TARO-MEROPENEM in Canada?

Yes. TARO-MEROPENEM 500MG has an active shortage reported to Health Canada (last updated July 14, 2026).

Why is TARO-MEROPENEM not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will TARO-MEROPENEM be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file3 products

Affected strength500MG

Report last updated2026-07-14

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

MEROPENEM FOR INJECTION, USP

FRESENIUS KABI CANADA LTD

500MG · DIN 02415216

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

MEROPENEM FOR INJECTION

SANDOZ CANADA INCORPORATED

500MG · DIN 02378787

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

MEROPENEM FOR INJECTION USP AND SODIUM CHLORIDE INJECTION USP

B. BRAUN MEDICAL INC

1G · DIN 02544342

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02421518

Strength

500MG

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS

Active Ingredient

MEROPENEM

See all MEROPENEM products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-07-14

Active Shortage

Disruption of the manufacture of the drug.

Other Products from SUN PHARMA CANADA INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

1MG · DIN 02365650

10MG · DIN 02313707

20MG · DIN 02313715

80MG · DIN 02313758

40MG · DIN 02313723

125MG · DIN 02329204